|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100044475 |
|
最近更新日期: Date of Last Refreshed on: |
2021-03-19 09:33:24 |
|
注册时间: Date of Registration: |
2021-03-19 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
前瞻性、多中心、随机对照、非劣效临床研究评价下肢外骨骼康复训练机器人的有效性和安全性 |
|
Public title: |
A prospective, multicenter, randomized controlled, non inferiority trial to evaluate the effectiveness and safety of the lower extremity exoskeleton |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
前瞻性、多中心、随机对照、非劣效临床研究评价下肢外骨骼康复训练机器人的有效性和安全性 |
|
Scientific title: |
A prospective, multicenter, randomized controlled, non inferiority trial to evaluate the effectiveness and safety of the lower extremity exoskeleton |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
许兰帅 |
研究负责人: |
励建安 |
|
Applicant: |
Xu Lanshuai |
Study leader: |
Li Jian'an |
|
申请注册联系人电话: Applicant telephone: |
+86 15118029255 |
研究负责人电话:
Study leader's |
+86 13705161766 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
xulanshuai0123@163.com |
研究负责人电子邮件: Study leader's E-mail: |
lijianan@carm.org.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
www.milebot.com.cn |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
广东省深圳市南山区高新南七道2号 |
研究负责人通讯地址: |
江苏省南京市栖霞区马群街169号 |
|
Applicant address: |
2 Seventh Gaoxin Road South, Nanshan District, Shenzhen, Guangdong, China |
Study leader's address: |
169 Maqun Street, Qixia District, Nanjing, Jiangsu, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
深圳市迈步机器人科技有限公司 |
||
|
Applicant's institution: |
Shenzhen Milebot Technology co.ltd. |
||
|
研究负责人所在单位: |
南京医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Nanjing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2019-MD-43 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京医科大学附属第一医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of Nanjing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2019-01-31 00:00:00 | ||
|
伦理委员会联系人: |
黄旭 |
||
|
Contact Name of the ethic committee: |
Huang Xu |
||
|
伦理委员会联系地址: |
江苏省南京市鼓楼区广州路300号 |
||
|
Contact Address of the ethic committee: |
300 Guangzhou Road, Gulou District, Nanjing, Jiangsu, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 025-68306360 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
jsphkj@163.com |
|
研究实施负责(组长)单位: |
南京医科大学第一附属医院 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Nanjing Medical University |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省南京市广州路300号 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
300 Guangzhou Road, Gulou District, Nanjing, Jiangsu, China |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
深圳市迈步机器人科技有限公司承担全部临床费用 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Shenzhen Maibu Robot Technology Co., Ltd. pay all clinical expenses |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
中风后偏瘫 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Hemiplegia after stroke |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
本临床试验旨在验证深圳市迈步机器人科技有限公司的下 肢外骨骼康复训练机器人 对 脑卒中导致下肢运动功能障碍的患者进行康复训练的有效性和安全性。 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this clinical trial is to verify the effectiveness and safety of lower extremity exoskeleton which manufactured by Shenzhen Milebot Technology Co. Ltd. for patients with stroke induced lower extremity motor dysfunction. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
本试验为前瞻性、多中心、随机对照,非劣效 临床试验。符合入选的受试者,随机分配到试验组或对照组。试验组为下肢外骨骼康复训练机器人训练,对照组为常规步行训练治疗。 试验组 :进行机器人辅助步行训练。机器人训练每日 2 次,每次 30 分钟,每周训练 5 天。患者需要根据病情进行常规康复治疗。在试验前,治疗 14 天、28 天进行功能指标评估。 对照组:进行 常规步行训练。常规步行训练每日 2 次,每次 30 分钟,每周训练 5 天 。患者需要根据病情进行常规康复治疗。在 试验前 ,治疗 14 天 、 28 天进行功能指标评估。 本试验通过下肢外骨骼康复训练机器人的临床使用观察并记录患者的步行能力步态对称性步频 步行周期 下肢感知功能和运动功能、肌张力等,以评价下肢外骨骼康复训练机器人的安全性及有效性。本试验由专业数据管理中心对所有相关的临床数据进行管理、由第三方统计中心对所有相关的临床数据进行统计分析。 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
This trial is prospective, multicenter, randomized control, non inferior clinical trial. The subjects who met the selection were randomly assigned to the test group or the control group. The test group was the lower limb exoskeleton rehabilitation training, and the control group was routine walking training. Test group: robot assisted walking training. The lower limb exoskeleton rehabilitation training is conducted twice a day, 30 minutes a time, and 5 days a week. Patients need to be treated according to their condition. The functional indicators were evaluated before the trial, 14 days and 28 days after treatment. Control group: routine walking training was carried out. Routine walking training is conducted twice a day, 30 minutes a time, and 5 days a week. Patients need to be treated according to their condition. Before the trial, the functional indicators were evaluated 14 days and 28 days after treatment. The test group was conducted to evaluate the safety and effectiveness of the robot by observing and recording the patients' walking ability gait symmetry gait frequency walking cycle lower limb perception function, motion function and muscle tension. The professional data management center manages all relevant clinical data and the third party statistical center conducts statistical analysis on all relevant clinical data. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
(1) 生命体征稳定 病情稳定,适宜进行运动试验 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
(1) The vital signs of patient are stable , suitable for exercise test |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
(1) 关节活动范围严重受限,限制步行动作 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
(1) The range of motion of joints is severely limited, which limits the walking movement |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2019-06-26 00:00:00至 To 2020-12-02 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2019-06-26 00:00:00 至 To 2020-11-05 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
统计专家采用随机数表法产生随机序列 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
a table of random numbers for random grouping by statistical experts |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
未进行 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
数据在如下网站进行公开:www.milebot.com.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Data will be public on the website:www.milebot.com.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
要求研究者或者助理研究者必须在患者训练或者评估当天填写CRF表和在线填写EDC系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
PI and SI are required to fill the CRF(Case Record Form) and EDC(Electronic Data Capture) at the same day when patient finish the training or evalutation. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |